Mouse CD90.2+ cells are either selected or depleted by incubating the sample with biotin conjugated anti-mouse CD90.2 antibody followed by Streptavidin Nanobeads. The magnetically labeled fraction is retained by the use of a magnetic separator. After collection of the CD90.2+ expressing cells, downstream applications include functional assays, gene expression, phenotypic characterization, etc.